NDAINHALATIONGAS
Approved
Oct 2018
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
3/8 — Basic
Drug data last refreshed 22h ago · AI intelligence enriched Yesterday
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HELIUM, USP is an inhaled gas product approved by the FDA in October 2018 under NDA type. The product is a medical-grade inhalation gas with no specified mechanism of action or pharmacologic classification in available data. Patient indications and therapeutic use cases are not detailed in the provided regulatory information.
Peak
Product is at peak lifecycle stage with low competitive pressure (30%), suggesting stable market position but limited growth acceleration opportunities for commercial team expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
Establishment of Biobank of Nasal Epithelium Samples From Healthy Volunteers
Started Sep 2026
120 enrolled
Healthy
Evaluate the Safety and Feasibility of Same-Day Bilateral Epithelium-On Corneal Cross-Linking for Keratoconus
Started May 2026
15 enrolled
Keratoconus
Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus
Started Nov 2023
398 enrolled
Keratoconus
Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus
Started Oct 2023
396 enrolled
Keratoconus
C2 Esophageal Squamous Epithelium Dysplasia
Started Nov 2022
129 enrolled
Esophageal Squamous Epithelium Dysplasia
Worked on HELIUM, USP at Advanced Solutions Life Sciences? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.